Top compounds associated with response to TM9SF3


Feature Type Standardized
Nominal ANOVA
mRNA PD-0332991 CCLE pan-cancer AAC 0.084 0.09
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.053 0.09
mRNA MS-275 FIMM pan-cancer AAC 0.23 0.09
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.09
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.062 0.09
mRNA CI-976 CTRPv2 pan-cancer AAC -0.071 0.09
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.064 0.09
mRNA CD-437 CTRPv2 pan-cancer AAC -0.059 0.09
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.056 0.09
Download CSV